Development and plasticity of meningeal lymphatic vessels

J Exp Med. 2017 Dec 4;214(12):3645-3667. doi: 10.1084/jem.20170391. Epub 2017 Nov 15.

Abstract

The recent discovery of meningeal lymphatic vessels (LVs) has raised interest in their possible involvement in neuropathological processes, yet little is known about their development or maintenance. We show here that meningeal LVs develop postnatally, appearing first around the foramina in the basal parts of the skull and spinal canal, sprouting along the blood vessels and cranial and spinal nerves to various parts of the meninges surrounding the central nervous system (CNS). VEGF-C, expressed mainly in vascular smooth muscle cells, and VEGFR3 in lymphatic endothelial cells were essential for their development, whereas VEGF-D deletion had no effect. Surprisingly, in adult mice, the LVs showed regression after VEGF-C or VEGFR3 deletion, administration of the tyrosine kinase inhibitor sunitinib, or expression of VEGF-C/D trap, which also compromised the lymphatic drainage function. Conversely, an excess of VEGF-C induced meningeal lymphangiogenesis. The plasticity and regenerative potential of meningeal LVs should allow manipulation of cerebrospinal fluid drainage and neuropathological processes in the CNS.

MeSH terms

  • Animals
  • Animals, Newborn
  • Biological Transport / drug effects
  • Cerebrospinal Fluid / metabolism
  • Dependovirus / metabolism
  • Gene Deletion
  • Humans
  • Indoles / pharmacology
  • Injections, Intraventricular
  • Lymph Nodes / drug effects
  • Lymph Nodes / metabolism
  • Lymphangiogenesis / drug effects
  • Lymphatic Vessels / drug effects
  • Lymphatic Vessels / physiology*
  • Male
  • Meninges / drug effects
  • Meninges / physiology*
  • Mice, Inbred C57BL
  • Microspheres
  • Myocytes, Smooth Muscle / drug effects
  • Myocytes, Smooth Muscle / metabolism
  • Protein Kinase Inhibitors / pharmacology
  • Pyrroles / pharmacology
  • Signal Transduction
  • Spinal Cord / drug effects
  • Spinal Cord / physiology
  • Sunitinib
  • Vascular Endothelial Growth Factor C / metabolism
  • Vascular Endothelial Growth Factor D / metabolism
  • Vascular Endothelial Growth Factor Receptor-3 / metabolism

Substances

  • Indoles
  • Protein Kinase Inhibitors
  • Pyrroles
  • Vascular Endothelial Growth Factor C
  • Vascular Endothelial Growth Factor D
  • Vascular Endothelial Growth Factor Receptor-3
  • Sunitinib